Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Entourage Liquid Fusionner is a cannabis-based hemp extract formulation developed by Entourage Phytolab. It utilizes the proprietary Fusionner™ technology, a water-soluble lipid delivery system designed to enhance the bioavailability of cannabinoids by approximately 50% and provide a rapid onset of action within 15 minutes. By creating a water-soluble system, the formulation partially bypasses first-pass metabolism, which reduces liver stress and improves therapeutic control compared to traditional oil-based cannabis products. The product is available in various concentrations, including a 'Night Use' variant that may incorporate additional cannabinoids such as cannabinol (CBN) alongside cannabidiol (CBD). Entourage Phytolab has advanced this technology into Phase 1 clinical trials in Brazil, targeting a range of conditions including chronic pain, epilepsy, and sleep disorders.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Entourage Liquid Fusionner.